Inactivation of dopamine beta-hydroxylase by beta-ethynyltyramine: kinetic characterization and covalent modification of an active site peptide.

beta-Ethynyltyramine has been shown to be a potent, mechanism-based inhibitor of dopamine beta-hydroxylase (DBH). This is evidenced by pseudo-first-order, time-dependent inactivation of enzyme, a dependence of inactivation on the presence of ascorbate and oxygen cosubstrates, the ability of tyramine (substrate) and 1-(3,5-difluoro-4-hydroxybenzyl)imidazole-2-thione (competitive multisubstrate inhibitor) to protect against inactivation, and a high affinity of beta-ethynyltyramine for enzyme. Inactivation of DBH by beta-ethynyltyramine is accompanied by stoichiometric, covalent modification of the enzyme. Analysis of the tryptic map following inactivation by [3H]-beta-ethynyltyramine reveals that the radiolabel is associated with a single, 25 amino acid peptide. The sequence of the modified peptide is shown to be Cys-Thr-Gln-Leu-Ala-Leu-Pro-Ala-Ser-Gly-Ile-His-Ile-Phe-Ala-Ser-Gln-Leu- His*- Thr-His-Leu-Thr-Gly-Arg, where His* corresponds to a covalently modified histidine residue. In studies using the separated enantiomers of beta-ethynyltyramine, we have found the R enantiomer to be a reversible, competitive inhibitor versus tyramine substrate with a Ki of 7.9 +/- 0.3 microM. The S enantiomer, while also being a competitive inhibitor (Ki = 33.9 +/- 1.4 microM), is hydroxylated by DBH to give the expected beta-ethynyloctopamine product and also efficiently inactivates the enzyme [kinact(app) = 0.18 +/- 0.02 min-1; KI(app) = 57 +/- 8 microM]. The partition ratio for this process is very low and has been estimated to be about 2.5. This establishes an approximate value for kcat of 0.45 min(-1) and reveals that (S)-beta-ethynyltyramine undergoes a slow turnover relative to that of tyramine (kcat approximately 50 s(-1), despite the nearly 100-fold higher affinity of the inactivator for enzyme.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  John A. Tainer,et al.  Structure and mechanism of copper, zinc superoxide dismutase , 1983, Nature.

[2]  P. Goodhart,et al.  Mechanism-based inactivation of dopamine beta-hydroxylase by p-cresol and related alkylphenols. , 1987, Biochemistry.

[3]  S. Udenfriend,et al.  Photometric assay of dopamine- -hydroxylase activity in human blood. , 1972, Clinical chemistry.

[4]  W. Hol,et al.  3.2 Å structure of the copper-containing, oxygen-carrying protein Panulirus interruptus haemocyanin , 1984, Nature.

[5]  P. Goodhart,et al.  Design and kinetic characterization of multisubstrate inhibitors of dopamine beta-hydroxylase. , 1986, Biochemistry.

[6]  S. Padgette,et al.  Olefin oxygenation and N-dealkylation by dopamine beta-monooxygenase: catalysis and mechanism-based inhibition. , 1985, Biochemistry.

[7]  J. Villafranca,et al.  Mechanism-based inhibitors of dopamine β-hydroxylase , 1987 .

[8]  S. Miller,et al.  Secondary isotope effects and structure-reactivity correlations in the dopamine beta-monooxygenase reaction: evidence for a chemical mechanism. , 1985, Biochemistry.

[9]  K. Yamasaki,et al.  Studies on the constituents of Gastrodia elata Blume. , 1981 .

[10]  C. Southan,et al.  Inactivation of dopamine beta-hydroxylase by p-cresol: isolation and characterization of covalently modified active site peptides. , 1988, Biochemistry.

[11]  R. A. Scott,et al.  The copper sites of dopamine beta-hydroxylase: an X-ray absorption spectroscopic study. , 1988, Biochemistry.

[12]  E. Ohlstein,et al.  Beta-substituted phenethylamines as high-affinity mechanism-based inhibitors of dopamine beta-hydroxylase. , 1988, Journal of medicinal chemistry.

[13]  P. Mueller,et al.  Dopamine beta-hydroxylase. Comparative specificities and mechanisms of the oxygenation reactions. , 1981, The Journal of biological chemistry.

[14]  W. Lovenberg,et al.  Inhibition of dopamine-β-hydroxylase by alternative electron donors , 1980 .

[15]  J. Peisach,et al.  Structural implications derived from the analysis of electron paramagnetic resonance spectra of natural and artificial copper proteins. , 1974, Archives of biochemistry and biophysics.

[16]  J. Mallet,et al.  The primary structure of human dopamine‐beta‐hydroxylase: insights into the relationship between the soluble and the membrane‐bound forms of the enzyme. , 1987, The EMBO journal.

[17]  J. Richardson,et al.  Crystal structure of bovine Cu,Zn superoxide dismutase at 3 A resolution: chain tracing and metal ligands. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Papadopoulos,et al.  Electron spin-echo studies of the copper(II) binding sites in dopamine beta-hydroxylase. , 1988, Biochemistry.

[19]  S. Kaufman,et al.  The enzymatic conversion of 3,4-dihydroxyphenylethylamine to norepinephrine. , 1960, The Journal of biological chemistry.

[20]  T. Flatmark,et al.  Dophamine β‐Hhydroxylase: Evidence against a ping‐pong mechanism , 1974 .

[21]  S. W. May,et al.  Asymmetric sulfoxidation by dopamine .beta.-hydroxylase, an oxygenase heretofore considered specific for methylene hydroxylation , 1980 .

[22]  N. Binsted,et al.  Direct structural information for the copper site of dopamine beta-mono-oxygenase obtained by using extended X-ray-absorption fine structure. , 1984, The Biochemical journal.

[23]  M. Gross,et al.  APPENDIX INHIBITION PATTERNS OBTAINED WHERE AN INHIBITOR IS PRESENT IN CONSTANT PROPORTION TO VARIABLE SUBSTRATE , 1973 .

[24]  J. Klinman,et al.  Mechanism of modulation of dopamine beta-monooxygenase by pH and fumarate as deduced from initial rate and primary deuterium isotope effect studies. , 1983, Biochemistry.

[25]  W. Cleland,et al.  The statistical analysis of enzyme kinetic data. , 1967, Advances in enzymology and related areas of molecular biology.

[26]  J. Daly,et al.  Substrates and inhibitors of dopamine-β-oxidase , 1962 .

[27]  D. Williams,et al.  Studies of enzyme-mediated reactions. Part VII. Stereospecific syntheses of tritium-labelled (2R)- and (2S)-dopamines: stereochemical course of hydroxylation of dopamine by dopamine beta-hydroxylase (E.C. 1.14.17.1). , 1976, Journal of the Chemical Society. Perkin transactions 1.